3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Head & Neck
1
Gynecologic
1
Conditions
Head and Neck Neoplasms
193
Squamous Cell Carcinoma of Head and Neck
171
Oropharyngeal Neoplasms
35
Carcinoma, Squamous Cell
26
Nasopharyngeal Carcinoma
24
Laryngeal Neoplasms
21
Mouth Neoplasms
20
Radiation Injuries
15
Nasopharyngeal Neoplasms
12
Hypopharyngeal Neoplasms
12
Salivary Gland Neoplasms
11
Xerostomia
8
Neoplasms
8
Mucositis
7
Laryngeal Diseases
7
Tongue Neoplasms
6
Esthesioneuroblastoma, Olfactory
6
Carcinoma, Non-Small-Cell Lung
6
Carcinoma
6
Thyroid Neoplasms
5
Lung Neoplasms
5
Recurrence
4
Prostatic Neoplasms
4
Melanoma
4
Breast Neoplasms
4
Thyroid Carcinoma, Anaplastic
3
Rectal Neoplasms
3
Pharyngeal Neoplasms
3
Paranasal Sinus Neoplasms
3
Pancreatic Neoplasms
3
Interventions
Radiotherapy, Intensity-Modulated
7
Cisplatin
7
Carboplatin
5
Surveys and Questionnaires
3
Paclitaxel
3
Taxes
2
Radiation
2
Docetaxel
2
Cetuximab
2
Albumin-Bound Paclitaxel
2
utomilumab
1
toripalimab
1
infigratinib
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
aldesleukin
1
Specimen Handling
1
Radiotherapy
1
Platinum
1
Nimorazole
1
Mass Screening
1
Liquid Biopsy
1
Immunoglobulin G
1
Hydroxyurea
1
Gene Expression Profiling
1
Focus Groups
1
Fluorouracil
1
Drug Therapy
1
Disulfides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Radiotherapy
×
Head & Neck
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts